PharmiWeb.com - Global Pharma News & Resources
19-Dec-2023

Almirall to participate in the 42nd Annual J.P. Morgan Healthcare Conference

BARCELONA, Spain. 19th December, 2023 – Almirall S.A. (BME: ALM), a global pharmaceutical company focused on medical dermatology, today announced its participation in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, USA from 8-11 January 2024.

Carlos Gallardo, Chairman and CEO of Almirall, is scheduled to give a presentation at 9 am Pacific Standard Time (6pm CET) on January 9th, 2024. The presentation will be available at https://www.almirall.com/investors and it will be streamed via webcast.

Furthermore, Almirall’s executive team will host one-on-one investor and business development meetings in San Francisco during the same period as the annual J.P. Morgan Healthcare Conference, running from January 8th to 11th, 2024. To explore this opportunity and schedule a meeting with Almirall's team, please do not hesitate to reach out to Mr. Pablo Divasson del Fraile via email at pablo.divasson@almirall.com.

About Almirall

Almirall is a global pharmaceutical company focused on medical dermatology. We collaborate with scientists and healthcare professionals to address patient’s needs through science to improve their lives.  Our Noble Purpose is at the core of our work: “Transform the patients' world by helping them realize their hopes and dreams for a healthy life”. We invest in differentiated and ground-breaking medical dermatology products to bring our innovative solutions to patients in need.

The company, founded in 1944 and headquartered in Barcelona, is publicly traded on the Spanish Stock Exchange (ticker: ALM). Throughout its 79-year history, Almirall has retained a strong focus on the needs of patients. Currently, Almirall has a direct presence in 21 countries and strategic agreements in over 70, with about 1,800 employees. Total revenues in 2022 were 878.5 million euros.         

For more information, please visit almirall.com

 

Media contact:

Tinkle

Laura Blằuez

lblazquez@tinkle.es

Phone: (+34) 600 430 581

 

Investors’ Relations contact

Almirall

Pablo Divasson del Fraile

pablo.divasson@almirall.com

Phone: (+34) 93 291 30 87

 

Corporate Communications contact:

Almirall

Mar Ramírez

mar.ramirez@almirall.com

Phone: (+34) 659 614 173

Editor Details

Last Updated: 19-Dec-2023